BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23094119)

  • 21. Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-gamma but not IL-4 is associated with the development of cutaneous lesions.
    Guevara-Mendoza O; Une C; Franceschi Carreira P; Orn A
    Scand J Immunol; 1997 Jul; 46(1):35-40. PubMed ID: 9246206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes.
    Xin L; Li K; Soong L
    Mol Immunol; 2008 Jul; 45(12):3371-82. PubMed ID: 18538399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
    J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice.
    Satoskar A; Al-Quassi HH; Alexander J
    Immunol Cell Biol; 1998 Apr; 76(2):159-66. PubMed ID: 9619486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
    Johnson LM; Scott P
    J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.
    Jones DE; Ackermann MR; Wille U; Hunter CA; Scott P
    Infect Immun; 2002 Apr; 70(4):2151-8. PubMed ID: 11895981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses.
    Carvalho LP; Pearce EJ; Scott P
    J Immunol; 2008 Nov; 181(9):6473-80. PubMed ID: 18941238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of
    Hurdayal R; Nieuwenhuizen NE; Khutlang R; Brombacher F
    Front Cell Infect Microbiol; 2019; 9():479. PubMed ID: 32039054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype.
    Bryson KJ; Millington OR; Mokgethi T; McGachy HA; Brombacher F; Alexander J
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e930. PubMed ID: 21245915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirements for Th1-dependent immunity against infection with Leishmania major.
    von Stebut E; Udey MC
    Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GK1 Improves the Immune Response Induced by Dendritic Cells of BALB/c Mice Infected with Leishmania mexicana Promastigotes.
    Gutiérrez-Kobeh L; Wilkins-Rodríguez AA
    Acta Parasitol; 2020 Mar; 65(1):27-35. PubMed ID: 31571138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.
    Varikuti S; Verma C; Natarajan G; Oghumu S; Satoskar AR
    Am J Pathol; 2021 May; 191(5):809-816. PubMed ID: 33539779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells.
    Goundry A; Romano A; Lima APCA; Mottram JC; Myburgh E
    FASEB J; 2018 Mar; 32(3):1315-1327. PubMed ID: 29097502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
    Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.
    Thomas BN; Buxbaum LU
    Infect Immun; 2008 Feb; 76(2):623-31. PubMed ID: 18070890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice.
    Daneshvar H; Hagan P; Phillips RS
    Parasite Immunol; 2003; 25(11-12):589-96. PubMed ID: 15053780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes.
    Bennett CL; Misslitz A; Colledge L; Aebischer T; Blackburn CC
    Eur J Immunol; 2001 Mar; 31(3):876-83. PubMed ID: 11241293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.